[Drug utilization decisions should be based on cost-benefit data].
Explore the source record for details and available documents.
Cost-Benefit Analysis↗
Biomedical subjects
Claes Rehnberg
Publications and source records attributed to Claes Rehnberg.
Biomedical subjects
Publications and source records attributed to Claes Rehnberg.
Explore the source record for details and available documents.